The novel Covid-19 pandemic gives rise to a global increase in ICU admissions.
Due to the nature of disease, the high incidence and a longer stay on intensive care, we can expect a tremendous increase in ICUAW (intensive care unit acquired weakness).
I wanted to ask if there is research conducted and data available describing the incidence and prevalence of CIP and CIM (critical illness polyneuropathy and myopathy resp.) post Covid-19.
I would like to know whether there is a predisposition for one or the other in function of a more specific rehabilitation.
Friendly greetings.
Hi Freek Van den Bossche:
Based on our ICU experience, we have still had no more than 15 mechanically ventilated patients recovered from COVID-19. Of these, many surprisingly have not developed ICU-AW (MRC-SS
This link can be of help:
1. https://www.medicaljournals.se/jrm/content/abstract/10.2340/16501977-2677V
2. https://www.medscape.com/viewarticle/927562
Article COVID-19: ICU delirium management during SARS-CoV-2 pandemic
Dear Freek Van den Bossche , although some time passed and more research has ben conducted, I stumbled across your question. Muhammad Yousuf and Palem Harinath great articles! @ Felipe González-Seguel interesting real life experience, thank you for sharing!
Here are 3 additional articles, whcih could be helpful to answer your question:
https://www.researchsquare.com/article/rs-78038/v1
In this article the authors detected, that CIN was more often present in Covid-19 patients, than in not Covid-19 patients and overall CIN/CIM incidence was higher in COVID-19.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660068/
https://www.researchgate.net/publication/344429474_Intensive_care_unit_acquired_muscle_weakness_in_COVID-19_patients
Hope that helps!
Hi Freek Van den Bossche, Great questioning, on a relevant topic, in addition to polyneuropathy and myopathy of the critical patient, we have polyneuropathy and myositis secondary to covid in front of them and their reflection in diagnosis and rehabilitation.